1 results for "Susan Sharp"
Showing 1–1 · 0.10 seconds · RSS
-
Journal Article
Dabrafenib and trametinib in Langerhans cell histiocytosis and other histiocytic disorders
The standard treatment for Langerhans cell histiocytosis (LCH) is chemotherapy, although the failure rates are high. Since MAP-kinase activating mutations are found in most cases, BRAF- and MEK-inhibitors have been used successfully to treat patients with refractory or relapsed disease. However…